In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Yarilet Perez is an experienced multimedia ...

Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University with ...

When fall has given way to winter and snow covers the ground while lights twinkle from house to house, you know that Christmas is coming. Christmas is one of the most important Christian and cultural ...

Steffini Stalos, DO, FCAP, is a pathology and lab medicine physician. She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Mean corpuscular hemoglobin concentration ...

Figure 1: High-score SR protein motifs in BRCA1 exon 18. Figure 3: Exon skipping correlates with the SF2/ASF enhancer motif score and not with reading frame disruption. When missense mutations are ...